Inventor · disambiguated record
Jianwen A. Feng
Also filed as: FENG JIANWEN · FENG JIANWEN A
35 granted patents·26 pending applications·120 citations·filing 2007–2025
96Inventor score
Files withDENALI THERAPEUTICS INC42GENENTECH INC15IDEXX LAB INC1PYXIS ONCOLOGY INC1SHIRE HUMAN GENETIC THERAPIES1
Top patents by PatentIndex Score
61 records- 0197US11111235B2Compounds, compositions, and methodsDENALI THERAPEUTICS INC·Filed 2020·Granted Sep 7, 2021·7 cites·26 claims
- 0297US9896458B2Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2017·Granted Feb 20, 2018·23 cites·6 claims
- 0397US9815850B2Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2017·Granted Nov 14, 2017·36 cites·41 claims
- 0496US9932325B2Compounds, compositions, and methodsDENALI THERAPEUTICS INC·Filed 2017·Granted Apr 3, 2018·16 cites·30 claims
- 0591US11306077B2Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2021·Granted Apr 19, 2022·2 cites·47 claims
- 0690US11591316B2Compounds, compositions, and methodsDENALI THERAPEUTICS INC·Filed 2021·Granted Feb 28, 2023·1 cites·20 claims
- 0790US10590114B2Compounds, compositions, and methodsDENALI THERAPEUTICS INC·Filed 2018·Granted Mar 17, 2020·5 cites·27 claims
- 0889US2025034119A1Compounds, compositions, and methodsDENALI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0988US9605005B2Alkynyl alcohols and methods of useGENENTECH INC·Filed 2016·Granted Mar 28, 2017·5 cites·4 claims
- 1086US10604535B2Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2018·Granted Mar 31, 2020·3 cites·18 claims
- 1186US10131676B2Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2017·Granted Nov 20, 2018·3 cites·33 claims
- 1285US12358928B2Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2023·Granted Jul 15, 2025·0 cites·8 claims
- 1385US11834439B2Compounds, compositions, and methodsDENALI THERAPEUTICS INC·Filed 2023·Granted Dec 5, 2023·0 cites·19 claims
- 1484US2025388601A1Compounds, Compositions and MethodsDENALI THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1583US11203600B2Kinase inhibitors and uses thereofDENALI THERAPEUTICS INC·Filed 2019·Granted Dec 21, 2021·2 cites·24 claims
- 1680US11236100B2Modulators of eukaryotic initiation factor 2B, compositions and methodsDENALI THERAPEUTICS INC·Filed 2018·Granted Feb 1, 2022·1 cites·30 claims
- 1780US10603364B2Lysosomal targeting and uses thereofSHIRE HUMAN GENETIC THERAPIES·Filed 2015·Granted Mar 31, 2020·2 cites·7 claims
- 1880US2025011338A1Kinase Inhibitors and Uses ThereofDENALI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1979US7449337B2Lytic reagent and method for leukocytes differential in whole bloodIDEXX LAB INC·Filed 2007·Granted Nov 11, 2008·10 cites·23 claims
- 2079US2024140919A1Modulators of eukaryotic initiation factor 2DENALI THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2176US11028080B2Substituted pyrimidines as LRKK2 inhibitorsDENALI THERAPEUTICS INC·Filed 2017·Granted Jun 8, 2021·1 cites·53 claims
- 2276US2023250072A1Modulators of eukaryotic initiation factor 2DENALI THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2375US11851440B2Modulators of eukaryotic initiation factor 2B, compositions and methodsDENALI THERAPEUTICS INC·Filed 2021·Granted Dec 26, 2023·0 cites·18 claims
- 2475US2025122159A1Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2573US12139478B2Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2018·Granted Nov 12, 2024·1 cites·57 claims
- 2673US2023043400A1Compounds, Compositions and MethodsDENALI THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2772US9034866B2Tricyclic compounds and methods of use thereforGENENTECH INC·Filed 2013·Granted May 19, 2015·2 cites·29 claims
- 2869US12180211B2Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2021·Granted Dec 31, 2024·0 cites·5 claims
- 2969US12129263B2Kinase inhibitors and uses thereofDENALI THERAPEUTICS INC·Filed 2021·Granted Oct 29, 2024·0 cites·19 claims
- 3069US2020317691A1Compounds, Compositions and MethodsDENALI THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3168US11958840B2Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2022·Granted Apr 16, 2024·0 cites·45 claims
- 3268US2022153728A1Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3367US11851433B2Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2021·Granted Dec 26, 2023·0 cites·17 claims
- 3467US11840529B2Substituted pyrimidines as LRKK2 inhibitorsDENALI THERAPEUTICS INC·Filed 2021·Granted Dec 12, 2023·0 cites·38 claims
- 3567US2022119371A1Compound, compositions, and methodsDENALI THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3666US2022332718A1PYRAZOLO[1,5a]PYRIMIDINE DERIVATIVES AS IRAK4 MODULATORSGENENTECH INC·Filed 2021·Application pending·0 cites
- 3765US11072618B2Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2019·Granted Jul 27, 2021·0 cites·17 claims
- 3865US2025388595A1Modulators of eukaryotic initiation factor 2b, compositions and methodsDENALI THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 3964US2021130308A1Modulators of eukaryotic initiation factor 2DENALI THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4064US2017362206A1Compounds, compositions, and methodsDENALI THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 4161US10988478B1Pyrazolo[1,5a]pyrimidine derivatives as IRAK4 modulatorsGENENTECH INC·Filed 2020·Granted Apr 27, 2021·0 cites·22 claims
- 4260US12091392B2Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2020·Granted Sep 17, 2024·0 cites·9 claims
- 4360US2025387499A1Ligand-payload conjugatesPYXIS ONCOLOGY INC·Filed 2023·Application pending·0 cites
- 4458US12358896B2LRRK2 inhibitors and methods of making and using thereofDENALI THERAPEUTICS INC·Filed 2020·Granted Jul 15, 2025·0 cites·18 claims
- 4558US2016096850A9Alkynyl alcohols and methods of useGENENTECH INC·Filed 2014·Application pending·0 cites
- 4658US2015057260A1Alkynyl alcohols and methods of useGENENTECH INC·Filed 2014·Application pending·0 cites
- 4757US2020157081A1Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4855US11174262B2Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2019·Granted Nov 16, 2021·0 cites·16 claims
- 4955US2018298015A1PYRAZOLO[1,5a]PYRIMIDINE DERIVATIVES AS IRAK4 MODULATORSGENENTECH INC·Filed 2018·Application pending·0 cites
- 5054US11214565B2Compound, compositions, and methodsDENALI THERAPEUTICS INC·Filed 2016·Granted Jan 4, 2022·0 cites·15 claims
Showing the top 50 of 61 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Jianwen A. Feng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →